The Paho Java Client is an MQTT client library written in Java for developing applications that run on the JVM or other Java compatible platforms such as Android The Paho Java Client provides two APIs ...

QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer ...

The Eclipse Foundation has launched a new initiative to motivate developers to report vulnerabilities in the Open VSX Registry. This vendor-independent platform for VS Code extensions, with over 300 ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The NGAD concept accelerated in the late 2010s, driven by concerns that the F-22 fleet was too small—with fewer than 200 airframes complete—and that the F-35, more of a digital node than a dogfighter, ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

The Eclipse IDE is remarkably simple to install on a Windows 10 or 11 computer. To install Eclipse on Windows, simply follow the five steps outlined in this video: Download the Eclipse IDE zip file ...

This repository contains example upload client scripts demonstrating use PHDO upload services. Once the hostname has been selected and token retrieved, those values must be set to environment ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’ve ever searched for information online about the ...

The code generated by large language models (LLMs) has improved some over time — with more modern LLMs producing code that has a greater chance of compiling — but at the same time, it's stagnating in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...